The developing cancer stem-cell model: clinical challenges and opportunities.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalOsteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesStem cell technology in breast cancer: current status and potential applicationsCancer Stem Cells in the ThyroidMultidrug resistance and cancer stem cells in neuroblastoma and hepatoblastomaCancer heterogeneity--a multifaceted viewModulation of the tumor microenvironment for cancer treatment: a biomaterials approachUnderstanding breast cancer stem cell heterogeneity: time to move on to a new research paradigmCan nanomedicines kill cancer stem cells?Chemoquiescence for ideal cancer treatment and prevention: where are we now?Concise Review: Induced Pluripotent Stem Cells as New Model Systems in OncologyThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisCharacterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agentsWhat Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer TissueResponse to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcomaIL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1LMultifunctional Nucleus-targeting Nanoparticles with Ultra-high Gene Transfection Efficiency for In Vivo Gene TherapyRenal cell carcinoma with synchronous ipsilateral urothelial carcinoma of the renal pelvis.Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.Debulking treatment with CT-guided percutaneous radiofrequency ablation and hepatic artery infusion of floxuridine improves survival of patients with unresectable pulmonary and hepatic metastases of colorectal cancerAn integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior.Current status of gene therapy for brain tumors.The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.Transcriptional shift identifies a set of genes driving breast cancer chemoresistanceNucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineCisplatin in 5% Ethanol Eradicates Cisplatin-Resistant Lung Tumor by Killing Lung Cancer Side Population (SP) Cells and Non-SP Cells.G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicSuppression of cancer relapse and metastasis by inhibiting cancer stemnessCancer stem cells as a target population for drug discovery.Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cellsCombination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo.G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.Gastric cancer stem cells: evidence, potential markers, and clinical implications.Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles.Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.Lewis Y antigen modified CD47 is an independent risk factor for poor prognosis and promotes early ovarian cancer metastasisQuercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin.
P2860
Q26744536-55A85371-77D4-4119-A363-1B91C77503D2Q26745742-87C48FE3-7715-4708-B258-70E78DE9B415Q26746223-B1010EAC-3194-401B-B7E8-AE85C6CA5909Q26765947-154CFEA9-8631-458C-B2D4-A06FDCE236B3Q26822652-917A04C9-E9E0-470A-8FC4-7D0BC2B42A57Q26829228-D2952F08-D13B-4873-A3C6-3EC4FC1301F6Q26996790-8F515D0B-2D05-4FAD-AE78-69736539CFC8Q26999684-18EE8389-FD38-4F7F-9711-05F0E6B07E14Q27022017-703E1AC0-8A23-4798-943F-D06A0BEDCE3BQ27026391-FF0B7D36-3BAF-41F2-B3E2-BB93D5B9E4F5Q28080945-C640731E-FBF8-4AC3-B68A-AAF7649A302DQ28388257-8FF448E9-B6BB-4E89-A6BF-2E68082EDAC1Q28546911-B7E2DAFD-BE9D-40A2-9EE7-A25CB029B242Q28552232-54A9F68C-6E08-4264-AFBB-8DEB0372B5A7Q31115121-2545D9E6-0E37-49F0-ABA7-366482EBA5AEQ33586736-5B935C2C-8807-4265-8362-E7BA6319BC40Q33655332-C45C9FC4-410C-4CE0-A722-0623B2D83645Q33703111-C2F4AF49-157F-424E-81EC-D88FE043E513Q33750860-DA838ADE-CCFA-4F43-93F5-862D56799292Q33762032-96273B08-DE69-41E6-9296-5BA1983D723BQ33763237-940B9D49-2463-4399-B493-38BE6A0F98A4Q33764110-6C370E73-DA74-4D87-9C28-98AF9F214BD7Q33926952-39492F0A-108D-4CB2-AD57-C14F6EC91DD1Q34050895-93576267-E03D-4DF0-BD18-F690772757A8Q34318157-73E184B0-EE11-49CD-B61D-0DBEA0786463Q34452128-0CBCE9F5-9D1B-4F81-805E-C6A4E823BE96Q34552025-610BC3B1-608A-41AA-BDF9-8656C826360DQ34698624-21F4EF68-6B36-49B5-9851-C83446337465Q34979432-8C870D52-EE81-43BE-8BE3-94CF065751D4Q34981973-39A14BA4-DF7D-490B-A0A2-31F400BB9F81Q35090120-24F3108C-F6F5-4987-AEE2-5F2BE7BA4A39Q35390334-9136A5DF-0762-4330-9FD5-02913CB75881Q35673201-F7B8D777-E3C5-423E-B286-EDDC2365897BQ35742348-D7741833-F5DC-4372-ABE6-B3962C0CF739Q35752008-64CA97B4-BA3C-42AC-BF43-1F85377CD0BCQ35795934-D2D03055-B3E0-418D-A59B-E01795439147Q35804266-154E0D1A-DE19-4FFB-BBCD-C2D90F9C84EBQ35832228-A6F5926D-8177-45B9-9490-7C77F7B76F63Q35853521-A3BE145F-3F18-4ABF-A1AE-9E11C7DB0B67Q36017156-95C6F822-BD71-48C3-8B14-AAA7A1C00B1B
P2860
The developing cancer stem-cell model: clinical challenges and opportunities.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The developing cancer stem-cell model: clinical challenges and opportunities.
@en
The developing cancer stem-cell model: clinical challenges and opportunities.
@nl
type
label
The developing cancer stem-cell model: clinical challenges and opportunities.
@en
The developing cancer stem-cell model: clinical challenges and opportunities.
@nl
prefLabel
The developing cancer stem-cell model: clinical challenges and opportunities.
@en
The developing cancer stem-cell model: clinical challenges and opportunities.
@nl
P2093
P1433
P1476
The developing cancer stem-cell model: clinical challenges and opportunities.
@en
P2093
Dick J Richel
Felipe de Sousa e Melo
Jan Paul Medema
P356
10.1016/S1470-2045(11)70257-1
P577
2012-02-01T00:00:00Z